NCT04114916View on ClinicalTrials.gov

Clinical Trial to Evaluate the Reduction of Cardiovascular Risk

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

December 22, 2018

Study Completion Date

December 30, 2018

Conditions
Cholesterol
Interventions
DIETARY_SUPPLEMENT

Apigenin, luteonin, grapefruit extract and citrolive

Two capsules daily at breakfast and dinner.

DIETARY_SUPPLEMENT

maltodextrina

Two capsules daily at breakfast and dinner.

Trial Locations (1)

30107

Catholic University of Murcia, Murcia

All Listed Sponsors
lead

Universidad Católica San Antonio de Murcia

OTHER

NCT04114916 - Clinical Trial to Evaluate the Reduction of Cardiovascular Risk | Biotech Hunter | Biotech Hunter